EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 11 (Novembre 2021) Med Sci (Paris), 37 11 (2021) 1035-1041 Références
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 11, Novembre 2021
Page(s) 1035 - 1041
Section Repères
DOI https://doi.org/10.1051/medsci/2021142
Publié en ligne 1 décembre 2021
  1. Ioannidis JP. How to make more published research true. PLoS Med 2014 ; 11 : e1001747. [CrossRef] [PubMed] [Google Scholar]
  2. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets?. Nat Rev Drug Discov 2011 ; 10 : 712. [CrossRef] [PubMed] [Google Scholar]
  3. De Lacey G, Record C, Wade J. How accurate are quotations and references in medical journals?. Br Med J 1985 ; 291 : 884–886. [CrossRef] [PubMed] [Google Scholar]
  4. Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ 2009 ; 339 : b2680. [CrossRef] [PubMed] [Google Scholar]
  5. Duyx B, Urlings MJE, Swaen GMH, et al. Scientific citations favor positive results: a systematic review and meta-analysis. J Clin Epidemiol 2017 ; 88 : 92–101. [CrossRef] [PubMed] [Google Scholar]
  6. Jergas H, Baethge C. Quotation accuracy in medical journal articles-a systematic review and meta-analysis. PeerJ 2015 ; 3 : e1364. [CrossRef] [PubMed] [Google Scholar]
  7. Mogull SA. Accuracy of cited facts in medical research articles: a review of study methodology and recalculation of quotation error rate. PLoS One 2017 ; 12 : e0184727. [CrossRef] [PubMed] [Google Scholar]
  8. Pavlovic V, Weissgerber T, Stanisavljevic D, et al. How accurate are citations of frequently cited papers in biomedical literature? Clin Sci (Lond) 2021; 135 : 671–81. [CrossRef] [PubMed] [Google Scholar]
  9. Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA 2007 ; 298 : 2517–2526. [CrossRef] [PubMed] [Google Scholar]
  10. Urlings MJE, Duyx B, Swaen GMH, et al. Citation bias and other determinants of citation in biomedical research: findings from six citation networks. J Clin Epidemiol 2021; 132 : 71–8. [CrossRef] [PubMed] [Google Scholar]
  11. Frank RA, Sharifabadi AD, Salameh JP, et al. Citation bias in imaging research: are studies with higher diagnostic accuracy estimates cited more often?. Eur Radiol 2019 ; 29 : 1657–1664. [CrossRef] [PubMed] [Google Scholar]
  12. Treanor L, Frank RA, Salameh JP, et al. Selective citation practices in imaging research: are diagnostic accuracy studies with positive titles and conclusions cited more often?. Am J Roentgenol 2019 ; 213 : 397–403. [CrossRef] [PubMed] [Google Scholar]
  13. Armstrong MF, Conduff JH, 3rd, Fenton JE, Coelho DH. Reference errors in otolaryngology-head and neck surgery literature. Otolaryngol Head Neck Surg 2018 ; 159 : 249–253. [CrossRef] [PubMed] [Google Scholar]
  14. Baethge C. Importance, errors, and patterns of quotations to psychiatric original articles. Pharmacopsychiatry 2020; 53 : 247–55. [CrossRef] [PubMed] [Google Scholar]
  15. Smith N, Cumberledge A. Quotation errors in general science journals: quotation errors in science journals. Proc Roy Soc A 2020; 476 : 20200538. [CrossRef] [Google Scholar]
  16. Hui A, Rains LS, Todd A, et al. The accuracy and accessibility of cited evidence: a study examining mental health policy documents. Soc Psychiatry Psychiatr Epidemiol 2020; 55 : 111–21. [CrossRef] [PubMed] [Google Scholar]
  17. Jalal H, Buchanich JM, Roberts MS, et al. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 2018; 361 : eaau1184. [CrossRef] [PubMed] [Google Scholar]
  18. Healton C, Pack R, Galea S. The opioid crisis, corporate responsibility, and lessons from the tobacco master settlement agreement. JAMA 2019 ; 322 : 2071–2072. [CrossRef] [PubMed] [Google Scholar]
  19. Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959–2017. JAMA 2019 ; 322 : 1996–2016. [CrossRef] [PubMed] [Google Scholar]
  20. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009 ; 99 : 221–227. [CrossRef] [PubMed] [Google Scholar]
  21. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA 2018 ; 320 : 2448–2460. [CrossRef] [PubMed] [Google Scholar]
  22. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med 2015 ; 162 : 276–286. [CrossRef] [PubMed] [Google Scholar]
  23. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980 ; 302 : 123. [Google Scholar]
  24. Leung PTM, Macdonald EM, Stanbrook MB, et al. A 1980 letter on the risk of opioid addiction. N Engl J Med 2017 ; 376 : 2194–2195. [CrossRef] [PubMed] [Google Scholar]
  25. Becker WC, Fiellin DA. Limited evidence, faulty reasoning, and potential for a global opioid crisis. BMJ 2017 ; 358 : j3115. [CrossRef] [PubMed] [Google Scholar]
  26. Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc 2018 ; 93 : 344–350. [CrossRef] [PubMed] [Google Scholar]
  27. Keng A, Coley RM. Evaluating the accuracy of citations in drug promotional brochures. Ann Pharmacother 1994 ; 28 : 1231–1235. [CrossRef] [PubMed] [Google Scholar]
  28. Gonzalez-Santiago M, Bucher HC, Nordmann AJ. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Med Inform Decis Mak 2008 ; 8 : 61. [CrossRef] [PubMed] [Google Scholar]
  29. Spielmans GI, Thielges SA, Dent AL, Greenberg RP. The accuracy of psychiatric medication advertisements in medical journals. J Nerv Ment Dis 2008 ; 196 : 267–273. [CrossRef] [PubMed] [Google Scholar]
  30. Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA 1994 ; 272 : 133–136. [CrossRef] [PubMed] [Google Scholar]
  31. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis 2020 : 101663. [CrossRef] [PubMed] [Google Scholar]
  32. Million M, Lagier JC, Gautret P, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille France. Travel Med Infect Dis 2020 : 101738. [CrossRef] [PubMed] [Google Scholar]
  33. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 : 1054–62. [CrossRef] [PubMed] [Google Scholar]
  34. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20 : 656–7. [CrossRef] [PubMed] [Google Scholar]
  35. Fiolet T, Guihur A, Rebeaud ME, et al. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect 2020 ; 27: 19–27. [Google Scholar]
  36. Juul S, Nielsen EE, Feinberg J, et al. Interventions for treatment of COVID-19: a living systematic review with meta-analyses and trial sequential analyses (The Living Project). PLoS Med 2020; 17 : e1003293. [CrossRef] [PubMed] [Google Scholar]
  37. Siemieniuk RA, Bartoszko JJ, Ge L, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ 2020; 370 : m2980. [CrossRef] [PubMed] [Google Scholar]
  38. Peiffer-Smadja N, Rebeaud ME, Guihur A, et al. Hydroxychloroquine and COVID-19: a tale of populism and obscurantism. Lancet Infect Dis 2021; 21 : e121. [CrossRef] [PubMed] [Google Scholar]
  39. Ektorp E. Death threats after a trial on chloroquine for COVID-19. Lancet Infect Dis 2020; 20 : 661. [CrossRef] [PubMed] [Google Scholar]
  40. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56 : 105949. [CrossRef] [PubMed] [Google Scholar]
  41. Kim AHJ, Sparks JA, Liew JW, et al. A Rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for Covid-19. Ann Intern Med 2020; 172 : 819–21. [CrossRef] [PubMed] [Google Scholar]
  42. Alperovitch A, Lazar P. L’éthique des essais thérapeutiques. Med Sci (Paris) 2020; 36 : 303–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  43. Amiel P, Chneiweiss H, Dosquet C. Covid-19 : protocoles de soins ou protocoles de recherche ? Med Sci (Paris) 2020; 36 : 521–3. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.